Minidex trial

Minidex: The efficacy and safety of very low dose dexamethasone used to facilitate the extubation of ventilator dependent preterm babies who are at high risk of bronchopulmonary dysplasia.

Minidex is a multi-centre randomised controlled trial comparing low dose dexamethasone to placebo for premature babies who are breathing with the support of a ventilator. We would like to find out if low dose dexamethasone is helpful, harmful, or makes no difference to the outcomes for these babies. Our early research suggests that it is helpful and with fewer side effects.

Recruitment
Total
022
Target
94

The Minidex trial is no longer recruiting.
We would like to thank all the families who took part.

Trial Information

EudraCT No.:
2015-005342-63
REC Reference:
16/NW/0396
ISRCTN:
81191607
Clinical Trials Unit:
National Perinatal Epidemiology Unit CTU
Sponsor:
Liverpool Women's Foundation NHS Trust
Funder:
The NIHR Efficacy and Mechanism Evaluation (EME) Programme